(Total Views: 83)
Posted On: 11/30/2025 2:07:21 PM
Post# of 5155

Share Structure - Updated November 28, 2025:
Transfer Agent Verified
Usually updated week after close Friday - view Saturday
No change to Outstanding Shares - no dilution - in 7 days
Authorized Shares: 12,000,000,000
Outstanding Shares: 6,821,124,405
Restricted: 283,572,035
Unrestricted: 6,537,552,370
Held At DTC: 6,526,343,050
Note 1: It is only the Held At DTC Shares count that is relevant to current trading provided it is updated at the same time as the Unrestricted Outstanding Shares count.
Note 2: Relatively low Held At DTC Shares count - only 6.5B - for a stock in the .0002 > .1 range.
Note 3: During the period of the increase November 8 > November 14, $ECOX traded 5.90B. The Held At DTC figure increase as a portion of the shares traded was 24.7% - exactly the same % as the increase in total Outstanding Shares.
Note 4: During the period of the increase November 15 > November 21, $ECOX traded 1.48B.
Note 5: During the period November 22 > November 28, there was no increase to the Outstanding Shares - the balance of 200M of the previous week's increase was traded in the DTC.
Note 6: Convertible notes payable as at September 30, 2025 were < $600K - has declined continually since to date - manageable compared to other OTC issuers - company intends to fully settle balance upon completion of the merger with WRA Holdings if not sooner. [source: PR November 12, 2025]
Note 7: No new debt financing in over 3 years and company does not intend to pursue dilutive financing arrangements going forward. [source: PR November 12, 2025]
Note 8: Company is currently in negotiations with the Preferred C holder to settle their remaining balance of ~$32,500 as of November 12, 2025. High levels of dilution November 7-12 were due to this class of debt. [source: PR November 12, 2025]
Note 9: Company remains committed to resolving this balance and has committed funding in place to settle this. The Company's efforts are focused exclusively on negotiating favorable settlements with remaining legacy creditors to eliminate these obligations and strengthen the Company's capital structure in preparation for the proposed merger. [source: PR November 12, 2025]
Note 10: Company has retired a significant portion of a preferred stock position that had previously been associated with high levels of potential dilution. No new securities were issued in connection with this retirement. [source: PR November 13, 2025]
Transfer Agent Verified
Usually updated week after close Friday - view Saturday
No change to Outstanding Shares - no dilution - in 7 days
Authorized Shares: 12,000,000,000
Outstanding Shares: 6,821,124,405
Restricted: 283,572,035
Unrestricted: 6,537,552,370
Held At DTC: 6,526,343,050
Note 1: It is only the Held At DTC Shares count that is relevant to current trading provided it is updated at the same time as the Unrestricted Outstanding Shares count.
Note 2: Relatively low Held At DTC Shares count - only 6.5B - for a stock in the .0002 > .1 range.
Note 3: During the period of the increase November 8 > November 14, $ECOX traded 5.90B. The Held At DTC figure increase as a portion of the shares traded was 24.7% - exactly the same % as the increase in total Outstanding Shares.
Note 4: During the period of the increase November 15 > November 21, $ECOX traded 1.48B.
Note 5: During the period November 22 > November 28, there was no increase to the Outstanding Shares - the balance of 200M of the previous week's increase was traded in the DTC.
Note 6: Convertible notes payable as at September 30, 2025 were < $600K - has declined continually since to date - manageable compared to other OTC issuers - company intends to fully settle balance upon completion of the merger with WRA Holdings if not sooner. [source: PR November 12, 2025]
Note 7: No new debt financing in over 3 years and company does not intend to pursue dilutive financing arrangements going forward. [source: PR November 12, 2025]
Note 8: Company is currently in negotiations with the Preferred C holder to settle their remaining balance of ~$32,500 as of November 12, 2025. High levels of dilution November 7-12 were due to this class of debt. [source: PR November 12, 2025]
Note 9: Company remains committed to resolving this balance and has committed funding in place to settle this. The Company's efforts are focused exclusively on negotiating favorable settlements with remaining legacy creditors to eliminate these obligations and strengthen the Company's capital structure in preparation for the proposed merger. [source: PR November 12, 2025]
Note 10: Company has retired a significant portion of a preferred stock position that had previously been associated with high levels of potential dilution. No new securities were issued in connection with this retirement. [source: PR November 13, 2025]
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.